email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2638-5945

Open Access Journal of Oncology and Medicine

Case Report(ISSN: 2638-5945)

Benign Metastasizing Leiomyoma and Intravenous Leiomyomatosis Following Total Hysterectomy: Two Case Reports and a Literature Review

Volume 2 - Issue 3

Nathaniel A Parker DO1*, Christopher SR Dakhil MD2, Shaker R Dakhil MD2 and Daniel Lalich MD3

  • Author Information Open or Close
    • 1Resident Physician, University of Kansas School of Medicine Wichita, Wichita, USA
    • 2Medical Oncologist, Cancer Center of Kansas, Wichita, USA
    • 3Department of Pathology, Wesley Medical Center, Wichita, USA

    *Corresponding author: Nathaniel A Parker, Resident Physician, University of Kansas School of Medicine-Wichita, Wichita, USA

Received: July 11, 2018;   Published: July 23, 2018

DOI: 10.32474/OAJOM.2018.02.000137

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Uterine leiomyomas are the most common gynecological tumor in women of reproductive age. These tumors are typically benign entities, but uncommonly transition toward tissues of malignant potential. Rare growth patterns of uterine leiomyomata have been observed which include benign metastasizing leiomyoma (BML), disseminated peritoneal leiomyomatosis (DPL), intravenous leiomyomatosis (IVL), retroperitoneal leiomyomatosis (RPL) and parasitic leiomyoma (PL). Metastasis of uterine fibroids most commonly appear several years after the diagnosis and removal of uterine leiomyomata by hysterectomy. For two women who sought treatment for BML and IVL in our clinic, we retrospectively outlined and

evaluated their specific genetic, pathological, and clinical features with the intention to

elucidate possible treatment options.

Abstract| Introduction| Case Reports| Discussion| Conclusion| Acknowledgement| References|